ArticleEuropean journal of neurology2025
Machine Learning Analysis Applied to Prediction of Early Progression Independent of Relapse Activity in Multiple Sclerosis Patients.
Article in European journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Systematic review and meta-analysis of machine learning models predicting massive hemorrhage protocol in trauma.Scientific reports · 2026Pooled it
- Early Prognostic Factors in Multiple Sclerosis: Clinical and Therapeutic Implications.Medicina (Kaunas, Lithuania) · 2026Pooled it
- Mechanistic Insights into the Role of Artificial Intelligence and Machine Learning in the Diagnosis and Management of Multiple Sclerosis.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026Review
- Assessing the Relative Importance of Imaging and Serum Biomarkers in Capturing Disability, Cognitive Impairment, and Clinical Progression in Multiple Sclerosis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Machine Learning Analysis Applied to Prediction of Early Progression Independent of Relapse Activity in Multiple Sclerosis Patients.European journal of neurology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
backgroundPredicting prognosis in people with multiple sclerosis (pwMS) at early disease stages still remains an unmet need. Machine learning (ML) strategies demonstrated good reliability when applied for prediction in medicine. This study aimed at developing a predictive algorithm comparing different ML approaches, by using routine demographic, clinical and radiological data from a large multicentric cohort of newly diagnosed pwMS.
methodsDemographic, clinical, radiological and biochemical data were retrospectively collected at three Italian MS centers at baseline and four timepoints thereafter (6, 12, 24, and 36 months). Data from the first evaluation and subsequent 2-year follow-up were analyzed, comparing different ML models (Random Forest, Extra Trees, XGBoost, Logistic Regression and Support Vector Classifier) to predict progression independent of relapse activity (PIRA) at year 3. To understand how features impacted the selected model's output, a ML explainability analysis was performed on the whole cohort and on specific subsets of patients, those aged under 45 and those NEDA-3 at the 2-year follow-up.
resultsData from 719 pwMS (age 34.6 ± 11.2 years); female sex 501 (70%) were analyzed. Ninety-two pwMS (13%) developed PIRA at year 3. Random Forest achieved the highest score, with a test set area under the ROC curve (AUC) of 0.75 ± 0.06. Features with the highest predictive impact were Expanded Disability Status Scale at 24 months, age at symptom onset and disease duration at baseline.
conclusionOur results showed the feasibility of applying ML techniques to predict short-term PIRA in newly diagnosed pwMS by using routine clinical practice data, paving the way for tailored and personalized approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.